KCT0004288尚未招募未知
A Randomized, Double-blinded, Placebo-controlled, Multi-center Phase 2 Study to Explore the Efficacy and Safety of Subcutaneous Injection EG-Myocin Immediately Before and After PCI in Patients with Acute ST-Elevation Myocardial Infarction (STEMI)
Eyegene0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •Ability to provide informed consent
- •- Male : 19 ~ 75 years, Female : 50 ~ 75 years
- •- ST-segment elevation myocardial infarction
- •- Able to consent for blood draw
排除标准
- •- Left main coronary artery
- •- Cardiac arrest or arrhythmia where CPR or unscheduled circulatory aids have been used during diagnosis
- •- Cardiac shock
- •- uncontrolled hypertension
- •- CABG, coronary artery bypass graft
- •- An arrhythmia patient who has clinically significant
- •- Severe renal disorders
- •- Severe liver disorders
- •- Medical history of malignant carcinoma within past 3 years
- •- Subjects who have hypersensitivity reaction anamnesis for components of Investigational Product.
- •- Treatment with other investigational agents or devices within the previous 30 days, planned use of investigational drugs or devices, or previous enrolment in this trial
研究者
相似试验
已完成
不适用
enzilumab Study in Healthy Korean SubjectsCodes for special purposesKCT0006851Telcon RF Pharmaceuticals20
已完成
不适用
A human study to Investigate the Effect of L.lactis CKDB001 Administration on Liver Aminotransferases in Subjects with Nonalcoholic Fatty Liver DiseaseKCT0007388Chong Kun Dang Bio120
招募中
1 期
Trial to evaluate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia PatientsCOVID-19 Pneumonia PatientsMedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862EUCTR2022-001152-42-BGShaperon, Inc.1,134
进行中（未招募）
1 期
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyEarly non-metastatic breast cancer and therapy-induced bone loss and fracturesMedDRA version: 21.1Level: PTClassification code 10065687Term: Bone lossSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 100000004864EUCTR2005-005275-15-ATAmgen Limited3,400
进行中（未招募）
1 期
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyEarly non-metastatic breast cancer and therapy-induced bone loss and fracturesMedDRA version: 21.1Level: PTClassification code 10065687Term: Bone lossSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 100000004864EUCTR2005-005275-15-SEAmgen Limited3,400